Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Autoantigens and Their Potential Post-translational Modification in EGPA and Severe Eosinophilic Asthma

NCT04671446 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04671446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Autoantigens and Their Potential Post-translational Modification in EGPA and Severe Eosinophilic Asthma
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
December 10, 2020
Completion date
May 5, 2024
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

churg-strauss syndrome, eosinophilic asthma, eosinophilic esophagitis, eosinophilic pneumonia